Previous Article | Next Article ![]()
Journal of Virology, October 1999, p. 8411-8414, Vol. 73, No. 10
Department of Infectious Diseases and Vaccine
Control1 and Division of Molecular
Genetics,
Received 12 May 1999/Accepted 16 July 1999
We previously reported that Daudi cells, a Burkitt's lymphoma cell
line, were capable of supporting productive infection of hepatitis C
virus (HCV). During continual cultivation after HCV infection, the
culture became resistant to interferons (IFNs). This resistant cell
line, coded as H-903, was used as host cells for replication of GB
virus C (GBV-C), also known as hepatitis G virus. GBV-C RNA was
detected in the culture by reverse transcription-PCR for more than 130 days after inoculation, while it was detected for 44 days but not later
in the parental IFN-sensitive Daudi cells. Productive infection of
GBV-C in the H-903 system was confirmed by serially inoculating
supernatants from infected cultures into uninfected cells. The viral E2
antigen was detected by immunofluorescence in the cells inoculated with
the fifth passage of GBV-C. The presumed capsid-coding region of the
viral genome in the inoculum, in the serially passaged virus, or in the
virus produced by a long-term culture was only 16 amino acids long,
suggesting that the GBV-C with a short core sequence was replication competent.
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Replication of GB Virus C (Hepatitis G Virus)
in Interferon-Resistant Daudi Cells
*
Corresponding author. Present address: Hepatitis
Viruses Section, LID/NIAID, National Institutes of Health, Building 7, Room 200, Bethesda, MD 20892-0740. Phone: (301) 496-6227. Fax: (301) 402-0524. E-mail: yshimizu{at}niaid.nih.gov.
Journal of Virology, October 1999, p. 8411-8414, Vol. 73, No. 10
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|